Changing Services, Changing Oncology Pharmacy COVID-19 Position Statement

During the COVID-19 pandemic, oncology pharmacy services have had to adapt quickly and innovatively to continue to provide care to cancer patients. This document outlines both the clinical and operational responses implemented by BOPA members during the initial phase of COVID-19.

For clinical services we summarise different examples of responses , the key role oncology pharmacy services play in this response and recommendations for continued oncology pharmacy involvement in the future.
For operational services we identify the benefits, opportunities, risks and challenges of the responses and further considerations for reviewing these responses.

The document also highlights some of the next steps oncology pharmacy services and the wider oncology service could take in planning for the future phase of the COVID-19 pandemic.

We hope BOPA members find this document useful as it shows how we in oncology pharmacy have a pivotal role in providing cancer care and that whatever the challenges of continuing to provide care in a post COVID-19 world, so long as we plan for the risks, take opportunities, prepare to adapt and share our learning as a community, we will be able to meet them.

To access the document you must be a free or paid member of BOPA. 

Latest News

By BOPA Committee on 4th May 2021

My Research – Session 4: Risk Predictions – Statistical versus Machine learning methods

Session 4 (Wednesday 12th May at 19:00 GMT) –  CLICK HERE to REGISTER   We would like to invite you to join our monthly ‘My Research’ sessions. These sessions are…

Read article
By BOPA Committee on 30th April 2021

ISOPP Immunotherapy Survey

Immunotherapy is an important emerging therapy in the treatment of malignant disease. ISOPP recognises and supports the contributions of pharmacy staff across international healthcare systems in providing safe and effective…

Read article
By BOPA Committee on 22nd April 2021

BOPA Corporate Membership Information **PUBLISHED**

Document explaining corporate membership information with answers to FAQ’s.   Available here 

Read article
By Alia Nizam - Specialist Oncology Pharmacist, CRUK - Information Lead on 21st April 2021

SACT CRUK Consent Forms – Germ Cell Cancer

The germ cell cancer SACT consent forms have been reviewed and updated. They are available on the CRUK website at: Any questions please let me know.    

Read article

24th BOPA Symposium 2021

Virtual Symposium 8th to 10th October 2021

Registration is now open!

Early Bird registration for 3 days £49
Late registration for 3 days £175

BOPA non-members:
Early Bird registration for 3 days £240
Late registration for 3 days £375

Please note the early-bird rate applies up until Monday 6th September 2021.

Everything you need to know